News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,546 Results
Type
Article (39572)
Company Profile (248)
Press Release (656726)
Section
Business (204238)
Career Advice (2007)
Deals (35433)
Drug Delivery (94)
Drug Development (81012)
Employer Resources (172)
FDA (16156)
Job Trends (14844)
News (345206)
Policy (32505)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2548)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49432)
ALS (83)
Alzheimer's disease (1349)
Antibody-drug conjugate (ADC) (108)
Approvals (16158)
Artificial intelligence (228)
Autoimmune disease (14)
Automation (14)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (24)
Breast cancer (246)
Cancer (1989)
Cardiovascular disease (160)
Career advice (1673)
Career pathing (29)
CAR-T (139)
Cell therapy (395)
Cervical cancer (18)
Clinical research (65701)
Collaboration (763)
Compensation (449)
Complete response letters (19)
COVID-19 (2580)
CRISPR (35)
C-suite (210)
Cystic fibrosis (98)
Data (1951)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (248)
Diagnostics (6332)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (111)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86214)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111692)
Executive appointments (638)
FDA (17257)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (686)
Gene editing (96)
Generative AI (18)
Gene therapy (276)
GLP-1 (684)
Government (4379)
Grass and pollen (4)
Guidances (48)
Healthcare (18805)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2710)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (86)
Interviews (311)
IPO (16485)
IRA (40)
Job creations (3629)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (452)
Leadership (15)
Legal (7901)
Liver cancer (70)
Lung cancer (291)
Lymphoma (133)
Machine learning (4)
Management (58)
Manufacturing (266)
MASH (60)
Medical device (13320)
Medtech (13325)
Mergers & acquisitions (19415)
Metabolic disorders (629)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1821)
NextGen: Class of 2025 (6515)
Non-profit (4476)
Northern California (2417)
Now hiring (37)
Obesity (339)
Opinion (201)
Ovarian cancer (72)
Pain (77)
Pancreatic cancer (76)
Parkinson's disease (132)
Partnered (20)
Patents (203)
Patient recruitment (93)
Peanut (46)
People (57121)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase I (20463)
Phase II (28932)
Phase III (21564)
Pipeline (1024)
Podcasts (44)
Policy (110)
Postmarket research (2563)
Preclinical (8654)
Press Release (64)
Prostate cancer (93)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (355)
Real estate (5904)
Recruiting (65)
Regulatory (22138)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (120)
Series B (78)
Service/supplier (11)
Sickle cell disease (50)
Southern California (2094)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (25)
United States (21086)
Vaccines (656)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (227)
Last 7 days (733)
Last 30 days (2737)
Last 365 days (33667)
2025 (7960)
2024 (35221)
2023 (40084)
2022 (51179)
2021 (55718)
2020 (54091)
2019 (46553)
2018 (35020)
2017 (32122)
2016 (31492)
2015 (37569)
2014 (31344)
2013 (26375)
2012 (28599)
2011 (29290)
2010 (27359)
Location
Africa (717)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37725)
Australia (6166)
California (5512)
Canada (1864)
China (474)
Colorado (245)
Connecticut (256)
Delaware (125)
Europe (80931)
Florida (818)
Georgia (192)
Idaho (57)
Illinois (495)
India (23)
Indiana (290)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (826)
Massachusetts (4144)
Michigan (209)
Minnesota (369)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1571)
New Mexico (28)
New York (1582)
North Carolina (916)
North Dakota (7)
Northern California (2417)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1253)
Puerto Rico (9)
Rhode Island (26)
South America (1096)
South Carolina (18)
South Dakota (1)
Southern California (2094)
Tennessee (92)
Texas (821)
Utah (164)
Virginia (128)
Washington D.C. (57)
Washington State (512)
West Virginia (3)
Wisconsin (49)
696,546 Results for "microbix biosystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Microbix Further Optimizes Capital Usage and Availability
March 27, 2025
·
5 min read
Press Releases
Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific
March 18, 2025
·
7 min read
Press Releases
Microbix Presenting at Investor Conference in B.C.
February 19, 2025
·
4 min read
Microbix Advances Test-Ingredient Manufacturing Capabilities
Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces that it has successfully adapted and extended the use of its bioreactor capabilities for production of another clinically and commercially-important test-ingredient.
June 4, 2024
·
5 min read
Business
Microbix Reports Strong Results for Q2 Fiscal 2024
Microbix Biosystems Inc. reports results for its second quarter and first half of fiscal 2024 ended March 31, 2024.
May 15, 2024
·
7 min read
Press Releases
Microbix Schedules Release of Results for Q1 Fiscal 2025
February 6, 2025
·
3 min read
Microbix’s Clot-Buster Drug Project Advances
Microbix Biosystems Inc. announces that its funding and commercialization partner, Sequel Pharma, LLC, has executed, with support from Microbix, an agreement with a leading international contract development and manufacturing organization for production of the active ingredient of Kinlytic® urokinase, a biologic drug for dissolving blood clots.
March 14, 2024
·
5 min read
Press Releases
Microbix Reports Strong Revenues & Earnings for Q1 Fiscal 2025
February 14, 2025
·
6 min read
Microbix Collaborator Introduces New Lab Accreditation Program
Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces that Labquality Ltd., a collaborator and customer, is presenting results of its use of Microbix Quality Assessment Products for accreditation of clinical labs for conducting molecular tests for antimicrobial-resistant strains of M. genitalium, a common sexually-transmitted infection.
April 25, 2024
·
5 min read
Microbix Schedules Release of Results for Q2 Fiscal 2024
Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its second quarter of fiscal 2024 ended March 31, 2024 prior to the start of trading on May 15, 2024.
May 8, 2024
·
3 min read
1 of 69,655
Next
